The aldose reductase inhibitor sorbinil does not prevent the impairment in nitric oxide-mediated neurotransmission in anococcygeus muscle from diabetic rats

European Journal of Pharmacology

Volumn 318, Issue 1, 1996, Pages 101-108

  Way, Kerrie J ^a   Reid, Julianne J ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

Aldose reductase; Anococcygeus muscle, rat; Diabetes; Nitrergic neurotransmission; Nitric oxide (NO); Sorbinil

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; CLONIDINE; GUANETHIDINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; SORBINIL; STREPTOZOCIN;

ANIMAL MODEL; ANIMAL TISSUE; ANOCOCCYGEUS MUSCLE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROSTIMULATION; GLUCOSE BLOOD LEVEL; MALE; NEUROTRANSMISSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ALDEHYDE REDUCTASE; ANALYSIS OF VARIANCE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ELECTRIC STIMULATION; IMIDAZOLES; IMIDAZOLIDINES; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE; NITROPRUSSIDE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0030604228     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00751-0     Document Type: Article

References (41)

1. Belai, A., J. Lincoln, P. Milner and G. Burnstock, 1988, Progressive changes in adrenergic, serotonergic, and peptidergic nerves in proximal colon of streptozotocin-diabetic rats, Gastroenterology 95, 1234.
2. Belai, A., R.A. Lefebvre and G. Burnstock, 1991, Motor activity and neurotransmitter release in the gastric fundus of streptozotocin-diabetic rats, Eur. J. Pharmacol. 194, 225.
3. Beyer-Mears, A., L. Ku and M.P. Cohen, 1984, Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil, Diabetes 33, 604.
4. Calcutt, N.A., A.P. Mizisin and M.W. Kalichman, 1994, Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve, Eur. J. Pharmacol. 251, 27.
5. Cameron, N.E. and M.A. Cotter, 1992, Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway, Diabetologia 35, 1011.
6. Cameron, N.E., M.B. Leonard, I.S. Ross and P.H. Whiting, 1986, The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat, Diabetologia 29, 168.
7. Dhital, K., J. Lincoln, O. Appenzeller and G. Burnstock, 1986, Adrenergic innervation of vasa and nervi nervorum of optic, sciatic, vagus and sympathetic nerve trunks in normal and streptozotocin-diabetic rats, Brain Res. 367, 39.
8. Engerman, R.L. and T.S. Kern, 1993, Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs, Diabetes 42, 820.
9. Florkowski, C.M., B.R. Rowe, S. Nightingale, T.C. Harvey and A.H. Barnett, 1991, Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy, Diabetes 40, 129.
10. Gabbay, K.H., 1973, The sorbitol pathway and the complications of diabetes, New Engl. J. Med. 288, 831.
11. Gabbay, K.H., L.O. Merola and R.A. Field, 1966, Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes, Science 151, 209.
12. Ganguly, P.K., K.S. Dhalla, I.R. Innes, R.E. Beamish and N.S. Dhalla, 1986, Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy, Circ. Res. 59, 684.
13. Gillespie, J.S., 1980, The physiology and pharmacology of the anococcygeus muscle, Trends Pharmacol. Sci. 1, 453.
14. Gillon, K.R.W., J.N. Hawthorne and D.R. Tomlinson, 1983, Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition, Diabetologia 25, 365.
15. Hale, P.J., M. Nattrass, S.H. Silverman, C. Sennit, C.M. Perkins, A. Uden and G. Sundkvist, 1987, Peripheral nerve concentrations of glucose, fructose, sorbitol and myoinositol in diabetic and non-diabetic patients, Diabetologia 30, 464.
16. Hosking, D.J., T. Bennett and J.R. Hampton, 1978, Diabetic autonomic neuropathy, Diabetes 27, 1043.
17. Judzewitsch, R.G., J.B. Jaspan, K.S. Polonsky, C.R. Weinberg, J.B. Halter, E. Halar, M.A. Pfeifer, C. Vukadinovic, L. Bernstein, M. Schneider, K.-Y. Liang, K.H. Gabbay, A.H. Rubenstein and D. Porte Jr., 1983, Aldose reductase inhibition improves nerve conduction velocity in diabetic patients, New Engl. J. Med. 308, 119.
18. Kikkawa, R., I. Hatanaka, H. Yasuda, N. Kobayashi and Y. Shigeta, 1984, Prevention of peripheral nerve dysfunction by an aldose reductase inhibitor in streptozotocin-diabetic rats, Metabolism 33, 212.
19. Lewin, I.G., I.A.D. O'Brien, M.H. Morgan and R.J.M. Corrall, 1984, Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy, Diabetologia 26, 445.
20. Li, C.G. and M.J. Rand, 1989, Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle, Clin. Exp. Pharmacol. Physiol. 16, 933.
21. Lincoln, J., J.T. Bokor, R. Crowe, S.G. Griffith, A.J. Haven and G. Burnstock, 1984, Myenteric plexus in streptozotocin-treated rats. Neurochemical and histochemical evidence for diabetic neuropathy in the gut, Gastroenterology 86, 654.
22. Luheshi, G.N. and M.A. Zar, 1990, Inhibitory effect of streptozotocin-induced diabetes on non-cholinergic motor transmission in rat detrusor and its prevention by sorbinil, Br. J. Pharmacol. 101, 411.
23. Malone, J.I., H. Leavengood, M.J. Peterson, M.M. O'Brien, M.G. Page and C.E. Aldinger, 1984, Red blood cell sorbitol as an indicator of polyol pathway activity. Inhibition by sorbinil in insulin-dependent diabetic subjects, Diabetes 33, 45.
24. Martyn, C.N., W. Reid, R.J. Young, D.J. Ewing and B.F. Clarke, 1987, Six-month treatment with sorbinil in asymptomatic diabetic neuropathy. Failure to improve abnormal nerve function, Diabetes 36, 987.
25. Nowak, T.V., B. Harrington, J.H. Kalbfleisch and J.M. Amatruda, 1986, Evidence for abnormal cholinergic neuromuscular transmission in diabetic rat small intestine, Gastroenterology 91, 124.
26. Peterson, M.J., R. Sarges, C.E. Aldinger and D.P. MacDonald, 1979, CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats, Metabolism 28, 456.
27. Rand, M.J., 1992, Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission, Clin. Exp. Pharmacol. Physiol. 19, 147.
28. Schmidt, R.E., S.B. Plurad, W.R. Sherman, J.R. Williamson and R.G. Tilton, 1989, Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozotocin-induced diabetic rats, Diabetes 38, 569.
29. Taylor, P.D., A.D. Wickenden, D.J. Mirrlees and L. Poston, 1994, Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat, Br. J. Pharmacol. 111, 42.
30. Tesfamariam, B., J.J. Palacino, R.M. Weisbrod and R.A. Cohen, 1993, Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta, J. Cardiovasc. Pharmacol. 21, 205.
31. Tilton, R.G., G. Pugliese, L.S. Larose, A.M. Faller, K. Chang, M.A. Province and J.R. Williamson, 1991, Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats, J. Diabetes Complications 4, 230.
32. Tilton, R.G., K. Chang, J.R. Nyengaard, M. Van Den Enden, Y. Ido and J.R. Williamson, 1995, Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozotocin-induced diabetic rats, Diabetes 44, 234.
33. Tomlinson, D.R., R.J. Moriarty and J.H. Mayer, 1984, Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor sorbinil, Diabetes 33, 470.
34. Van Heyningen, R., 1959, Formation of polyols by the lens of the rat with sugar cataract, Nature 184, 194.
35. Ward, J.D., R.W.R. Baker and B.H. Davis, 1972, Effect of blood sugar control on the accumulation of sorbitol and fructose in nervous tissues, Diabetes 21, 1173.
36. Way, K.J. and J.J. Reid, 1994a, Nitric oxide-mediated neurotransmission is attenuated in the anococcygeus muscle from diabetic rats, Diabetologia 37, 232.
37. Way, K.J. and J.J. Reid, 1994b, Effect of aminoguanidine on the impaired nitric oxide-mediated neurotransmission in anococcygeus muscle from diabetic rats, Neuropharmacology 33, 1315.
38. Way, K.J. and J.J. Reid, 1995, Effect of diabetes and elevated glucose on nitric oxide-mediated neurotransmission in rat anococcygeus muscle, Br. J. Pharmacol. 115, 409.
39. Yagihashi, S., M. Kamijo, Y. Ido and D.J. Mirrlees, 1990, Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructure and morphometric studies of sural nerve in streptozotocin-induced diabetic rats, Diabetes 39, 690.
40. +-ATPase activity in rats maintained on L-fucose diet, Diabetes 42, 1401.
41. Yue, D.K., M.A. Hanwell, P.M. Satchell and J.R. Turtle, 1982, The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats, Diabetes 31, 789.